New York: Resources to Combat Misinformation
The New York government created website resources for the public to combat misinformation about COVID-19 illness and vaccines.
AIM Products
The Association of Immunization Managers tools and resources help our members to implement and manage effective immunization programs.
Washington: Training Collaboration for Pediatric Residents
The Washington DOH has engaged with Seattle Children's Hospital and the University of Washington REACH pathway program.
AIM: Talking Points About GBS and J&J Vaccine
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.
December 2021 ACIP Recommendation on Johnson & Johnson Vaccine
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the ACIP recommendation regarding the Johnson & Johnson COVID-19 vaccine.
2023 AIM Leadership in Action Conference
These slide decks and accompanying resources were presented at the 2023 AIM Leadership in Action Conference. Scroll to find presentations from leadership trainings, breakouts, award winners, and more! For any…
Press Release: 46 Immunization Advocates Receive National Recognition for Contributions to Vaccine Access
This press release announces the 46 awardees of the 2024 Immunization Champion Award.
2023 AIM Leadership in Action Conference Presentations
View the session descriptions and presentations from the 2023 AIM Leadership in Action Conference.
COVID-19 Vaccines: Vaccine Safety FAQs, Dispelling Vaccine Myths
This PowerPoint slide set was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to answer frequently asked questions about COVID-19 vaccine safety and dispel common myths about COVID-19 vaccines.
Washington: Power of Providers (POP) Initiative
The Power of Providers (POP) Initiative is an innovative program that leverages healthcare providers by supporting their conversations about COVID-19 vaccines.